Eukaryotic translation initiation factor 2 subunit alpha (EIF2α) is the regulatory subunit of the eIF2 heterotrimeric GTPase complex, which controls the rate-limiting step of protein synthesis initiation. Phosphorylation of EIF2α at Ser51 serves as the central hub for the integrated stress response (ISR), coordinating translational attenuation in response to diverse cellular stresses including ER stress, amino acid deprivation, viral infection, and oxidative damage[@wek2018].
In neurodegenerative diseases, aberrant EIF2α phosphorylation contributes to synaptic dysfunction, memory impairment, and neuronal death. The EIF2α pathway represents a major therapeutic target for Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS, and prion disorders[@ma2020].
¶ Structure and Domains
EIF2α contains:
- N-terminal domain (1-185): Contains the critical Ser51 phosphorylation site within a flexible loop; interacts with GTP-binding subunit
- Central β-barrel domain (186-280): Provides structural scaffold
- C-terminal OB-fold domain (281-315): Mediates interactions with eIF2β and eIF2γ subunits
The eIF2 complex delivers initiator methionyl-tRNA (Met-tRNAi) to the 40S ribosomal subunit in a GTP-dependent manner. GTP hydrolysis and GDP release are required for each translation initiation cycle[@hinnebusch2014].
eIF2•GTP•Met-tRNAi ternary complex formation is essential for every round of translation initiation. The complex:
- Binds the 40S ribosomal subunit
- Scans mRNA 5' UTRs for start codons
- Enables AUG start codon recognition
- GTP hydrolysis releases eIF2-GDP for recycling
Four kinases phosphorylate EIF2α at Ser51 in response to distinct stressors[@donnelly2013]:
| Kinase |
Stress Signal |
Pathway |
| PERK (EIF2AK3) |
ER stress/unfolded proteins |
Unfolded Protein Response |
| GCN2 (EIF2AK4) |
Amino acid starvation |
Amino acid deprivation |
| PKR (EIF2AK2) |
Viral dsRNA |
Antiviral response |
| HRI (EIF2AK1) |
Heme deficiency/oxidative stress |
Erythropoiesis, oxidative stress |
Phosphorylated EIF2α (p-EIF2α) inhibits eIF2B, the GTP exchange factor, reducing ternary complex availability and global protein synthesis by 50-90%[@pakoszebrucka2016].
Paradoxically, p-EIF2α enhances translation of specific mRNAs with upstream open reading frames (uORFs), including:
- ATF4: Transcription factor activating stress response genes
- CHOP (DDIT3): Pro-apoptotic transcription factor
- GADD34: PPP1R15A, feedback phosphatase regulatory subunit
In AD brains, elevated p-EIF2α and ATF4 levels correlate with disease progression[@hoozemans2007]:
- PERK activation: Accumulation of misfolded Aβ and tau activates the UPR
- Synaptic plasticity: p-EIF2α impairs long-term potentiation (LTP) and memory consolidation
- BACE1 translation: Paradoxically, p-EIF2α increases BACE1 via uORF bypass, enhancing Aβ production
- Neuronal death: Sustained CHOP expression promotes apoptosis
eIF2α phosphorylation is elevated in hippocampal neurons of AD patients and APP/PS1 transgenic mice[@oconnor2008].
- α-synuclein aggregates activate PERK in dopaminergic neurons
- PINK1/Parkin dysfunction impairs mitochondrial protein quality control, triggering ER stress
- Dopaminergic vulnerability: Substantia nigra neurons show elevated p-PERK and p-EIF2α
Post-mortem PD brains show increased p-PERK and p-EIF2α in surviving dopaminergic neurons[@hoozemans2005].
- PolyQ-expanded huntingtin disrupts ER homeostasis
- Chronic UPR activation contributes to striatal neuron degeneration
- BDNF translation: p-EIF2α impairs dendritic BDNF synthesis, affecting synaptic plasticity
¶ ALS and FTD
- TDP-43 cytoplasmic aggregates activate the ISR
- C9orf72 dipeptide repeats induce ER stress
- SOD1 mutations trigger PERK activation in motor neurons
- FUS pathology associated with PERK-p-EIF2α signaling
- PrP^Sc accumulation activates PERK and PKR
- Sustained p-EIF2α critical for prion neurotoxicity
- ISRIB rescues prion-induced synaptic deficits in models
ISRIB stabilizes eIF2B, restoring translation despite p-EIF2α[@sidrauski2013]:
- Mechanism: Binds eIF2B, counteracts p-EIF2α-mediated inhibition
- Preclinical: Improves memory, protects neurons in AD/PD/HD models
- Clinical: Not yet in human trials for neurodegeneration
- GSK2606414: Potent PERK inhibitor, neuroprotective in prion and tau models
- GSK2656157: Improved brain penetration
- Limitations: Pancreatic toxicity due to essential PERK function in secretory cells
- A-92: Selective GCN2 inhibitor
- Potential: May reduce ISR in specific contexts
- Mechanism: Inhibits GADD34/PP1 phosphatase, sustaining p-EIF2α
- Paradox: Protective in some models, harmful in others
- Interpretation: Context-dependent; acute vs chronic activation
| Interactor |
Relationship |
Disease Relevance |
| PERK |
Phosphorylates Ser51 |
ER stress, AD/PD/ALS |
| GCN2 |
Phosphorylates Ser51 |
Amino acid stress |
| PKR |
Phosphorylates Ser51 |
Viral, neuroinflammation |
| HRI |
Phosphorylates Ser51 |
Oxidative stress |
| eIF2B |
Target of p-EIF2α |
Translation regulation |
| GADD34/PP1 |
Dephosphorylates Ser51 |
ISR resolution |
| ATF4 |
Translation enhanced |
Stress response |
- Wek RC. Role of eIF2α kinases in translational control and adaptation to cellular stress. Cold Spring Harb Perspect Biol. 2018;10(7):a032861, https://doi.org/10.1101/cshperspect.a032861 (2018))
- Ma T et al. Dysregulation of the eIF2α kinase PERK in neurodegeneration. Brain Res. 2020;1742:146907, https://doi.org/10.1016/j.brainres.2020.146907 (2020))
- Hinnebusch AG. The scanning mechanism of eukaryotic translation initiation. Annu Rev Biochem. 2014;83:779-812, https://doi.org/10.1146/annurev-biochem-060713-035802 (2014))
- Donnelly N et al. The eIF2α kinases: their structures and functions. Cell Mol Life Sci. 2013;70(19):3493-3511, https://doi.org/10.1007/s00018-012-1252-6 (2013))
- Pakos-Zebrucka K et al. The integrated stress response. EMBO Rep. 2016;17(10):1374-1395, https://doi.org/10.15252/embr.201642195 (2016))
- Hoozemans JJM et al. Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun. 2007;354(3):707-711, https://doi.org/10.1016/j.bbrc.2006.12.169 (2007))
- O'Connor T et al. Phosphorylation of translation initiation factor eIF2α increases BACE1 levels. Neurobiol Aging. 2008;29(1):113-123, https://doi.org/10.1016/j.neurobiolaging.2006.08.012 (2008))
- Hoozemans JJM et al. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol. 2005;166(4):1281-1291, https://doi.org/10.1016/S0002-9440(10)62314-0 (2005)
- Sidrauski C et al. Pharmacological brake-release of mRNA translation enhances cognitive memory. eLife. 2013;2:e00498, https://doi.org/10.7554/eLife.00498 (2013))